Adaptive Biotechnologies Corp (ADPT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 35M 70M 105M Q3 '21: 39.5M Q4 '21: 37.9M Q1 '22: 38.6M Q2 '22: 43.7M Q3 '22: 47.8M Q4 '22: 55.2M Q1 '23: 37.6M Q2 '23: 48.9M Q3 '23: 37.9M Q4 '23: 45.8M Q1 '24: 41.9M Q2 '24: 43.2M Q3 '24: 46.4M Q4 '24: 47.5M Q1 '25: 52.4M Q2 '25: 58.9M Q3 '25: 94M Q4 '25: 71.7M Q1 '26: 70.9M Q2 '26: 71.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 30M 60M 90M Q3 '21: 25.3M Q4 '21: 23.6M Q1 '22: 25.4M Q2 '22: 30.4M Q3 '22: 32.9M Q4 '22: 38.6M Q1 '23: 19M Q2 '23: 31M Q3 '23: 18.6M Q4 '23: 26.2M Q1 '24: 23.8M Q2 '24: 23.9M Q3 '24: 29.8M Q4 '24: 29.4M Q1 '25: 35.5M Q2 '25: 40.9M Q3 '25: 75.8M Q4 '25: 53.5M Q1 '26: 52.2M Q2 '26: 51.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -56.3M Q4 '21: -61.6M Q1 '22: -63.1M Q2 '22: -52.5M Q3 '22: -45.4M Q4 '22: -39.2M Q1 '23: -57.2M Q2 '23: -47.8M Q3 '23: -51M Q4 '23: -71.1M Q1 '24: -48.8M Q2 '24: -47.3M Q3 '24: -32.6M Q4 '24: -33.8M Q1 '25: -29.6M Q2 '25: -25M Q3 '25: 10.3M Q4 '25: -12.8M Q1 '26: -19.2M Q2 '26: -15.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -55.9M Q4 '21: -61.4M Q1 '22: -62.7M Q2 '22: -52M Q3 '22: -45.3M Q4 '22: -40.1M Q1 '23: -57.7M Q2 '23: -47.8M Q3 '23: -50.3M Q4 '23: -69.4M Q1 '24: -47.5M Q2 '24: -46.2M Q3 '24: -32.1M Q4 '24: -33.7M Q1 '25: -29.9M Q2 '25: -25.6M Q3 '25: 9.5M Q4 '25: -13.6M Q1 '26: -20M Q2 '26: -39.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 7M 14M 21M Q3 '21: 14.2M Q4 '21: 14.4M Q1 '22: 13.2M Q2 '22: 13.2M Q3 '22: 14.9M Q4 '22: 16.6M Q1 '23: 18.7M Q2 '23: 17.9M Q3 '23: 19.3M Q4 '23: 19.6M Q1 '24: 18.1M Q2 '24: 19.3M Q3 '24: 16.7M Q4 '24: 18M Q1 '25: 17M Q2 '25: 18M Q3 '25: 18.2M Q4 '25: 18.2M Q1 '26: 18.7M Q2 '26: 20.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -43.4M Q4 '21: -53.8M Q1 '22: -64.5M Q2 '22: -47.1M Q3 '22: -42.4M Q4 '22: -30M Q1 '23: -59.2M Q2 '23: -23.6M Q3 '23: -46.7M Q4 '23: -26.9M Q1 '24: -38.4M Q2 '24: -17.3M Q3 '24: -27.1M Q4 '24: -12.5M Q1 '25: -28.5M Q2 '25: -12.4M Q3 '25: -7.1M Q4 '25: 2.1M Q1 '26: -9.5M Q2 '26: -6.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-75M -50M -25M 0 25M 50M 75M Q3 '21: -58.1M Q4 '21: -63.1M Q1 '22: -67.5M Q2 '22: -52.4M Q3 '22: -47.8M Q4 '22: -32.6M Q1 '23: -62.1M Q2 '23: -27.3M Q3 '23: -49.5M Q4 '23: -28.2M Q1 '24: -39.9M Q2 '24: -19M Q3 '24: -27.4M Q4 '24: -12.6M Q1 '25: -29.7M Q2 '25: -13.1M Q3 '25: -7.5M Q4 '25: 1.4M Q1 '26: -10.3M Q2 '26: -7.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q2 '21: 140.4M Q3 '21: 140.8M Q1 '22: 141.7M Q2 '22: 142.4M Q3 '22: 142.9M Q1 '23: 143.5M Q2 '23: 144.4M Q3 '23: 144.7M Q1 '24: 145.8M Q2 '24: 147.4M Q3 '24: 147.5M Q1 '25: 149.2M Q2 '25: 152.1M Q3 '25: 163.2M Q1 '26: 155.5M Q2 '26: 159.9M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '21: -1.36 Q4 '21: -1.48 Q1 '22: -1.63 Q2 '22: -1.65 Q3 '22: -1.57 Q4 '22: -1.41 Q1 '23: -1.37 Q2 '23: -1.33 Q3 '23: -1.36 Q4 '23: -1.56 Q1 '24: -1.49 Q2 '24: -1.47 Q3 '24: -1.34 Q4 '24: -1.08 Q1 '25: -0.95 Q2 '25: -0.81 Q3 '25: -0.53 Q4 '25: -0.40 Q1 '26: -0.33 Q2 '26: -0.41 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.